A second dose of kisspeptin-54 improves oocyte maturation in women at high risk of ovarian hyperstimulation syndrome: a Phase 2 randomized controlled trial
Ali Abbara(National Health Service), Waljit S. Dhillo(Imperial College London), Geoffrey Trew(Hammersmith Hospital), Chioma Izzi‐Engbeaya(Hammersmith Hospital), Julia Prague(Hammersmith Hospital), Alexander Nesbitt(American Society for Investigative Pathology), Alexander Comninos(National Health Service), Rachel Roberts(Imperial College London), Sunitha Vimalesvaran(Hammersmith Hospital), Sophie Clarke(Imperial College London), Rumana Islam(Hammersmith Hospital), Stuart Lavery(Hammersmith Hospital), Rehan Salim(Hammersmith Hospital), Les Huson(Hammersmith Hospital), Deborah Papadopoulou(Imperial College London), Stephen R. Bloom(Imperial College London), Shakunthala Narayanaswamy(Hammersmith Hospital), Risheka Ratnasabapathy(Hammersmith Hospital)
Cited by 69
Related Papers
Inhibition of Food Intake in Obese Subjects by Peptide YY<sub>3–36</sub>
|New England Journal of Medicine|2003|1.6k
Human distribution and release of a putative new gut hormone, peptide YY
|Gastroenterology|1985|1.1k
Gut Hormone Profiles Following Bariatric Surgery Favor an Anorectic State, Facilitate Weight Loss, and Improve Metabolic Parameters
|Annals of Surgery|2005|982
Gut Hormones as Mediators of Appetite and Weight Loss After Roux-en-Y Gastric Bypass
|Annals of Surgery|2007|735
Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653